The global Bio-Micro-Electro-Mechanical Systems (BioMEMS) market in 2026 has reached a significant milestone, with a projected valuation of $6.53 billion as it continues its steady climb toward $35 billion by 2035. While the concept of miniaturized medical devices has existed for years, 2026 is the year where "Lab-on-a-Chip" (LOC) platforms have transitioned from expensive research tools to...
The future of hidradenitis suppurativa (HS) care is shaped by emerging technologies like AI-driven drug discovery and personalized treatment strategies. These innovations promise to uncover new targets, tailor therapies to individual patients, and address unmet needs, driving the HS market’s growth and redefining standards of care.
AI is accelerating drug development. Machine learning...
Market Overview
The global genotyping market size was valued at USD 18.58 billion in 2024 and is projected to grow from USD 21.24 billion in 2025 to reach USD 61.96 billion in 2033, growing at a CAGR of 14.32% during the forecast period (2025–2033). The market is being propelled by technological advances, falling DNA sequencing costs, and expanding...
Using Pharmacogenomics to Predict Drug Response
The concept of Personalized medicine in Schizophrenia hinges on the ability to predict how an individual will respond to a specific treatment before it is administered. Pharmacogenomics, the study of how genes affect a person's response to drugs, is becoming a reality. Genetic tests can now identify variations in liver enzymes (like...
The Healthcare Digital Twin is paving the way for hyper-personalized medicine by offering clinicians a virtual testing ground for individual patients. Creating a patient-specific digital human twin involves synthesizing a massive amount of individualized data—including multi-omics data (genomics, proteomics), detailed physiological measurements, and even lifestyle metrics—to...